Global Gastrointestinal Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Gastrointestinal market report explains the definition, types, applications, major countries, and major players of the Gastrointestinal market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Nycomed (Takeda)

    • Qilu Pharmaceutical Group

    • Novartis

    • Yangtze Pharmaceutical Group

    • Zhejiang Asia-pacific Pharmaceutical

    • Shandong Luoxin Pharmaceutical Group

    • Amgen

    • AstraZeneca

    • Pfizer

    • Allergan

    • AbbVie

    • Huadong Medicine

    • Tillotts Pharma

    • Livzon Pharmaceutical Group

    • Merck

    • Inner Mongolia Shuangqi Pharmaceutic

    • CTTQ

    • Beijing Kaiyin Technology

    • CSPC

    • Chengdu Tiantaishan Pharmaceutical

    • Abbott

    • Johnson & Johnson

    • GlaxoSmithKline

    • Sanofi

    • Solvay

    • Jiangsu Aosaikang Pharmaceutical

    • Shire Pharmaceuticals

    • Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

    • Roche

    • Eli Lilly

    By Type:

    • Esophagus Diseases Drug

    • Stomach Trouble Drug

    • Colon Disease Drug

    • Small Intestinal Diseases Drug

    • Liver Disease Drug

    • Pancreatic Disease Drug

    • Gallbladder Disease Drug

    • Other

    By End-User:

    • Pharmaceutical And Biotechnology Companies

    • Hospital

    • Pharmacy

    • Outpatient Surgical Centers And Clinics

    • Academic And Research Organizations

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Gastrointestinal Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Gastrointestinal Outlook to 2028- Original Forecasts

    • 2.2 Gastrointestinal Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Gastrointestinal Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Gastrointestinal Market- Recent Developments

    • 6.1 Gastrointestinal Market News and Developments

    • 6.2 Gastrointestinal Market Deals Landscape

    7 Gastrointestinal Raw Materials and Cost Structure Analysis

    • 7.1 Gastrointestinal Key Raw Materials

    • 7.2 Gastrointestinal Price Trend of Key Raw Materials

    • 7.3 Gastrointestinal Key Suppliers of Raw Materials

    • 7.4 Gastrointestinal Market Concentration Rate of Raw Materials

    • 7.5 Gastrointestinal Cost Structure Analysis

      • 7.5.1 Gastrointestinal Raw Materials Analysis

      • 7.5.2 Gastrointestinal Labor Cost Analysis

      • 7.5.3 Gastrointestinal Manufacturing Expenses Analysis

    8 Global Gastrointestinal Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Gastrointestinal Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Gastrointestinal Export by Region (Top 10 Countries) (2017-2028)

    9 Global Gastrointestinal Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastrointestinal Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Esophagus Diseases Drug Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Stomach Trouble Drug Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Colon Disease Drug Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Small Intestinal Diseases Drug Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Liver Disease Drug Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Pancreatic Disease Drug Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Gallbladder Disease Drug Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastrointestinal Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmaceutical And Biotechnology Companies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Outpatient Surgical Centers And Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Academic And Research Organizations Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Gastrointestinal Market Analysis and Outlook till 2022

    • 10.1 Global Gastrointestinal Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Gastrointestinal Consumption (2017-2022)

      • 10.2.2 Canada Gastrointestinal Consumption (2017-2022)

      • 10.2.3 Mexico Gastrointestinal Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Gastrointestinal Consumption (2017-2022)

      • 10.3.2 UK Gastrointestinal Consumption (2017-2022)

      • 10.3.3 Spain Gastrointestinal Consumption (2017-2022)

      • 10.3.4 Belgium Gastrointestinal Consumption (2017-2022)

      • 10.3.5 France Gastrointestinal Consumption (2017-2022)

      • 10.3.6 Italy Gastrointestinal Consumption (2017-2022)

      • 10.3.7 Denmark Gastrointestinal Consumption (2017-2022)

      • 10.3.8 Finland Gastrointestinal Consumption (2017-2022)

      • 10.3.9 Norway Gastrointestinal Consumption (2017-2022)

      • 10.3.10 Sweden Gastrointestinal Consumption (2017-2022)

      • 10.3.11 Poland Gastrointestinal Consumption (2017-2022)

      • 10.3.12 Russia Gastrointestinal Consumption (2017-2022)

      • 10.3.13 Turkey Gastrointestinal Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Gastrointestinal Consumption (2017-2022)

      • 10.4.2 Japan Gastrointestinal Consumption (2017-2022)

      • 10.4.3 India Gastrointestinal Consumption (2017-2022)

      • 10.4.4 South Korea Gastrointestinal Consumption (2017-2022)

      • 10.4.5 Pakistan Gastrointestinal Consumption (2017-2022)

      • 10.4.6 Bangladesh Gastrointestinal Consumption (2017-2022)

      • 10.4.7 Indonesia Gastrointestinal Consumption (2017-2022)

      • 10.4.8 Thailand Gastrointestinal Consumption (2017-2022)

      • 10.4.9 Singapore Gastrointestinal Consumption (2017-2022)

      • 10.4.10 Malaysia Gastrointestinal Consumption (2017-2022)

      • 10.4.11 Philippines Gastrointestinal Consumption (2017-2022)

      • 10.4.12 Vietnam Gastrointestinal Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Gastrointestinal Consumption (2017-2022)

      • 10.5.2 Colombia Gastrointestinal Consumption (2017-2022)

      • 10.5.3 Chile Gastrointestinal Consumption (2017-2022)

      • 10.5.4 Argentina Gastrointestinal Consumption (2017-2022)

      • 10.5.5 Venezuela Gastrointestinal Consumption (2017-2022)

      • 10.5.6 Peru Gastrointestinal Consumption (2017-2022)

      • 10.5.7 Puerto Rico Gastrointestinal Consumption (2017-2022)

      • 10.5.8 Ecuador Gastrointestinal Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Gastrointestinal Consumption (2017-2022)

      • 10.6.2 Kuwait Gastrointestinal Consumption (2017-2022)

      • 10.6.3 Oman Gastrointestinal Consumption (2017-2022)

      • 10.6.4 Qatar Gastrointestinal Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Gastrointestinal Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Gastrointestinal Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Gastrointestinal Consumption (2017-2022)

      • 10.7.2 South Africa Gastrointestinal Consumption (2017-2022)

      • 10.7.3 Egypt Gastrointestinal Consumption (2017-2022)

      • 10.7.4 Algeria Gastrointestinal Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Gastrointestinal Consumption (2017-2022)

      • 10.8.2 New Zealand Gastrointestinal Consumption (2017-2022)

    11 Global Gastrointestinal Competitive Analysis

    • 11.1 Nycomed (Takeda)

      • 11.1.1 Nycomed (Takeda) Company Details

      • 11.1.2 Nycomed (Takeda) Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Nycomed (Takeda) Gastrointestinal Main Business and Markets Served

      • 11.1.4 Nycomed (Takeda) Gastrointestinal Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Qilu Pharmaceutical Group

      • 11.2.1 Qilu Pharmaceutical Group Company Details

      • 11.2.2 Qilu Pharmaceutical Group Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Qilu Pharmaceutical Group Gastrointestinal Main Business and Markets Served

      • 11.2.4 Qilu Pharmaceutical Group Gastrointestinal Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Novartis

      • 11.3.1 Novartis Company Details

      • 11.3.2 Novartis Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Novartis Gastrointestinal Main Business and Markets Served

      • 11.3.4 Novartis Gastrointestinal Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Yangtze Pharmaceutical Group

      • 11.4.1 Yangtze Pharmaceutical Group Company Details

      • 11.4.2 Yangtze Pharmaceutical Group Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Yangtze Pharmaceutical Group Gastrointestinal Main Business and Markets Served

      • 11.4.4 Yangtze Pharmaceutical Group Gastrointestinal Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Zhejiang Asia-pacific Pharmaceutical

      • 11.5.1 Zhejiang Asia-pacific Pharmaceutical Company Details

      • 11.5.2 Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Main Business and Markets Served

      • 11.5.4 Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Shandong Luoxin Pharmaceutical Group

      • 11.6.1 Shandong Luoxin Pharmaceutical Group Company Details

      • 11.6.2 Shandong Luoxin Pharmaceutical Group Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Shandong Luoxin Pharmaceutical Group Gastrointestinal Main Business and Markets Served

      • 11.6.4 Shandong Luoxin Pharmaceutical Group Gastrointestinal Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Amgen

      • 11.7.1 Amgen Company Details

      • 11.7.2 Amgen Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Amgen Gastrointestinal Main Business and Markets Served

      • 11.7.4 Amgen Gastrointestinal Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 AstraZeneca

      • 11.8.1 AstraZeneca Company Details

      • 11.8.2 AstraZeneca Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 AstraZeneca Gastrointestinal Main Business and Markets Served

      • 11.8.4 AstraZeneca Gastrointestinal Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Pfizer

      • 11.9.1 Pfizer Company Details

      • 11.9.2 Pfizer Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Pfizer Gastrointestinal Main Business and Markets Served

      • 11.9.4 Pfizer Gastrointestinal Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Allergan

      • 11.10.1 Allergan Company Details

      • 11.10.2 Allergan Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Allergan Gastrointestinal Main Business and Markets Served

      • 11.10.4 Allergan Gastrointestinal Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 AbbVie

      • 11.11.1 AbbVie Company Details

      • 11.11.2 AbbVie Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 AbbVie Gastrointestinal Main Business and Markets Served

      • 11.11.4 AbbVie Gastrointestinal Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Huadong Medicine

      • 11.12.1 Huadong Medicine Company Details

      • 11.12.2 Huadong Medicine Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Huadong Medicine Gastrointestinal Main Business and Markets Served

      • 11.12.4 Huadong Medicine Gastrointestinal Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Tillotts Pharma

      • 11.13.1 Tillotts Pharma Company Details

      • 11.13.2 Tillotts Pharma Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Tillotts Pharma Gastrointestinal Main Business and Markets Served

      • 11.13.4 Tillotts Pharma Gastrointestinal Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Livzon Pharmaceutical Group

      • 11.14.1 Livzon Pharmaceutical Group Company Details

      • 11.14.2 Livzon Pharmaceutical Group Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Livzon Pharmaceutical Group Gastrointestinal Main Business and Markets Served

      • 11.14.4 Livzon Pharmaceutical Group Gastrointestinal Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Merck

      • 11.15.1 Merck Company Details

      • 11.15.2 Merck Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Merck Gastrointestinal Main Business and Markets Served

      • 11.15.4 Merck Gastrointestinal Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Inner Mongolia Shuangqi Pharmaceutic

      • 11.16.1 Inner Mongolia Shuangqi Pharmaceutic Company Details

      • 11.16.2 Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Main Business and Markets Served

      • 11.16.4 Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 CTTQ

      • 11.17.1 CTTQ Company Details

      • 11.17.2 CTTQ Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 CTTQ Gastrointestinal Main Business and Markets Served

      • 11.17.4 CTTQ Gastrointestinal Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 Beijing Kaiyin Technology

      • 11.18.1 Beijing Kaiyin Technology Company Details

      • 11.18.2 Beijing Kaiyin Technology Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 Beijing Kaiyin Technology Gastrointestinal Main Business and Markets Served

      • 11.18.4 Beijing Kaiyin Technology Gastrointestinal Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 CSPC

      • 11.19.1 CSPC Company Details

      • 11.19.2 CSPC Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 CSPC Gastrointestinal Main Business and Markets Served

      • 11.19.4 CSPC Gastrointestinal Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 Chengdu Tiantaishan Pharmaceutical

      • 11.20.1 Chengdu Tiantaishan Pharmaceutical Company Details

      • 11.20.2 Chengdu Tiantaishan Pharmaceutical Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 Chengdu Tiantaishan Pharmaceutical Gastrointestinal Main Business and Markets Served

      • 11.20.4 Chengdu Tiantaishan Pharmaceutical Gastrointestinal Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    • 11.21 Abbott

      • 11.21.1 Abbott Company Details

      • 11.21.2 Abbott Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.21.3 Abbott Gastrointestinal Main Business and Markets Served

      • 11.21.4 Abbott Gastrointestinal Product Portfolio

      • 11.21.5 Recent Research and Development Strategies

    • 11.22 Johnson & Johnson

      • 11.22.1 Johnson & Johnson Company Details

      • 11.22.2 Johnson & Johnson Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.22.3 Johnson & Johnson Gastrointestinal Main Business and Markets Served

      • 11.22.4 Johnson & Johnson Gastrointestinal Product Portfolio

      • 11.22.5 Recent Research and Development Strategies

    • 11.23 GlaxoSmithKline

      • 11.23.1 GlaxoSmithKline Company Details

      • 11.23.2 GlaxoSmithKline Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.23.3 GlaxoSmithKline Gastrointestinal Main Business and Markets Served

      • 11.23.4 GlaxoSmithKline Gastrointestinal Product Portfolio

      • 11.23.5 Recent Research and Development Strategies

    • 11.24 Sanofi

      • 11.24.1 Sanofi Company Details

      • 11.24.2 Sanofi Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.24.3 Sanofi Gastrointestinal Main Business and Markets Served

      • 11.24.4 Sanofi Gastrointestinal Product Portfolio

      • 11.24.5 Recent Research and Development Strategies

    • 11.25 Solvay

      • 11.25.1 Solvay Company Details

      • 11.25.2 Solvay Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.25.3 Solvay Gastrointestinal Main Business and Markets Served

      • 11.25.4 Solvay Gastrointestinal Product Portfolio

      • 11.25.5 Recent Research and Development Strategies

    • 11.26 Jiangsu Aosaikang Pharmaceutical

      • 11.26.1 Jiangsu Aosaikang Pharmaceutical Company Details

      • 11.26.2 Jiangsu Aosaikang Pharmaceutical Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.26.3 Jiangsu Aosaikang Pharmaceutical Gastrointestinal Main Business and Markets Served

      • 11.26.4 Jiangsu Aosaikang Pharmaceutical Gastrointestinal Product Portfolio

      • 11.26.5 Recent Research and Development Strategies

    • 11.27 Shire Pharmaceuticals

      • 11.27.1 Shire Pharmaceuticals Company Details

      • 11.27.2 Shire Pharmaceuticals Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.27.3 Shire Pharmaceuticals Gastrointestinal Main Business and Markets Served

      • 11.27.4 Shire Pharmaceuticals Gastrointestinal Product Portfolio

      • 11.27.5 Recent Research and Development Strategies

    • 11.28 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

      • 11.28.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details

      • 11.28.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.28.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Main Business and Markets Served

      • 11.28.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Product Portfolio

      • 11.28.5 Recent Research and Development Strategies

    • 11.29 Roche

      • 11.29.1 Roche Company Details

      • 11.29.2 Roche Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.29.3 Roche Gastrointestinal Main Business and Markets Served

      • 11.29.4 Roche Gastrointestinal Product Portfolio

      • 11.29.5 Recent Research and Development Strategies

    • 11.30 Eli Lilly

      • 11.30.1 Eli Lilly Company Details

      • 11.30.2 Eli Lilly Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

      • 11.30.3 Eli Lilly Gastrointestinal Main Business and Markets Served

      • 11.30.4 Eli Lilly Gastrointestinal Product Portfolio

      • 11.30.5 Recent Research and Development Strategies

    12 Global Gastrointestinal Market Outlook by Types and Applications to 2028

    • 12.1 Global Gastrointestinal Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Esophagus Diseases Drug Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Stomach Trouble Drug Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Colon Disease Drug Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Small Intestinal Diseases Drug Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Liver Disease Drug Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Pancreatic Disease Drug Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Gallbladder Disease Drug Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Gastrointestinal Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pharmaceutical And Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Outpatient Surgical Centers And Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Academic And Research Organizations Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Gastrointestinal Market Analysis and Outlook to 2028

    • 13.1 Global Gastrointestinal Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Gastrointestinal Consumption Forecast (2022-2028)

      • 13.2.2 Canada Gastrointestinal Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Gastrointestinal Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.2 UK Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.3 Spain Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.5 France Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.6 Italy Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.8 Finland Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.9 Norway Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.11 Poland Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.12 Russia Gastrointestinal Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Gastrointestinal Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.2 Japan Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.3 India Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Gastrointestinal Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Gastrointestinal Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Gastrointestinal Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Gastrointestinal Consumption Forecast (2022-2028)

      • 13.5.3 Chile Gastrointestinal Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Gastrointestinal Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Gastrointestinal Consumption Forecast (2022-2028)

      • 13.5.6 Peru Gastrointestinal Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Gastrointestinal Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Gastrointestinal Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Gastrointestinal Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Gastrointestinal Consumption Forecast (2022-2028)

      • 13.6.3 Oman Gastrointestinal Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Gastrointestinal Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Gastrointestinal Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Gastrointestinal Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Gastrointestinal Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Gastrointestinal Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Gastrointestinal Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Gastrointestinal Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Gastrointestinal Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Gastrointestinal Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Gastrointestinal

    • Figure of Gastrointestinal Picture

    • Table Global Gastrointestinal Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Gastrointestinal Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Esophagus Diseases Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Stomach Trouble Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Colon Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Small Intestinal Diseases Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Liver Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Pancreatic Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Gallbladder Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical And Biotechnology Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Outpatient Surgical Centers And Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Academic And Research Organizations Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Consumption by Country (2017-2022)

    • Table North America Gastrointestinal Consumption by Country (2017-2022)

    • Figure United States Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Canada Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Mexico Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Table Europe Gastrointestinal Consumption by Country (2017-2022)

    • Figure Germany Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure UK Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Spain Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Belgium Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure France Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Italy Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Denmark Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Finland Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Norway Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Sweden Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Poland Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Russia Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Turkey Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Table APAC Gastrointestinal Consumption by Country (2017-2022)

    • Figure China Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure India Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Thailand Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Singapore Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Philippines Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Table South America Gastrointestinal Consumption by Country (2017-2022)

    • Figure Brazil Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Colombia Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Chile Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Argentina Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Peru Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Table GCC Gastrointestinal Consumption by Country (2017-2022)

    • Figure Bahrain Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Oman Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Qatar Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Table Africa Gastrointestinal Consumption by Country (2017-2022)

    • Figure Nigeria Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure South Africa Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Egypt Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Algeria Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Table Oceania Gastrointestinal Consumption by Country (2017-2022)

    • Figure Australia Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Table Nycomed (Takeda) Company Details

    • Table Nycomed (Takeda) Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nycomed (Takeda) Gastrointestinal Main Business and Markets Served

    • Table Nycomed (Takeda) Gastrointestinal Product Portfolio

    • Table Qilu Pharmaceutical Group Company Details

    • Table Qilu Pharmaceutical Group Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Pharmaceutical Group Gastrointestinal Main Business and Markets Served

    • Table Qilu Pharmaceutical Group Gastrointestinal Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Gastrointestinal Main Business and Markets Served

    • Table Novartis Gastrointestinal Product Portfolio

    • Table Yangtze Pharmaceutical Group Company Details

    • Table Yangtze Pharmaceutical Group Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yangtze Pharmaceutical Group Gastrointestinal Main Business and Markets Served

    • Table Yangtze Pharmaceutical Group Gastrointestinal Product Portfolio

    • Table Zhejiang Asia-pacific Pharmaceutical Company Details

    • Table Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Main Business and Markets Served

    • Table Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Product Portfolio

    • Table Shandong Luoxin Pharmaceutical Group Company Details

    • Table Shandong Luoxin Pharmaceutical Group Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shandong Luoxin Pharmaceutical Group Gastrointestinal Main Business and Markets Served

    • Table Shandong Luoxin Pharmaceutical Group Gastrointestinal Product Portfolio

    • Table Amgen Company Details

    • Table Amgen Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Gastrointestinal Main Business and Markets Served

    • Table Amgen Gastrointestinal Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Gastrointestinal Main Business and Markets Served

    • Table AstraZeneca Gastrointestinal Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Gastrointestinal Main Business and Markets Served

    • Table Pfizer Gastrointestinal Product Portfolio

    • Table Allergan Company Details

    • Table Allergan Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Gastrointestinal Main Business and Markets Served

    • Table Allergan Gastrointestinal Product Portfolio

    • Table AbbVie Company Details

    • Table AbbVie Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Gastrointestinal Main Business and Markets Served

    • Table AbbVie Gastrointestinal Product Portfolio

    • Table Huadong Medicine Company Details

    • Table Huadong Medicine Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Huadong Medicine Gastrointestinal Main Business and Markets Served

    • Table Huadong Medicine Gastrointestinal Product Portfolio

    • Table Tillotts Pharma Company Details

    • Table Tillotts Pharma Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tillotts Pharma Gastrointestinal Main Business and Markets Served

    • Table Tillotts Pharma Gastrointestinal Product Portfolio

    • Table Livzon Pharmaceutical Group Company Details

    • Table Livzon Pharmaceutical Group Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Livzon Pharmaceutical Group Gastrointestinal Main Business and Markets Served

    • Table Livzon Pharmaceutical Group Gastrointestinal Product Portfolio

    • Table Merck Company Details

    • Table Merck Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Gastrointestinal Main Business and Markets Served

    • Table Merck Gastrointestinal Product Portfolio

    • Table Inner Mongolia Shuangqi Pharmaceutic Company Details

    • Table Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Main Business and Markets Served

    • Table Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Product Portfolio

    • Table CTTQ Company Details

    • Table CTTQ Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table CTTQ Gastrointestinal Main Business and Markets Served

    • Table CTTQ Gastrointestinal Product Portfolio

    • Table Beijing Kaiyin Technology Company Details

    • Table Beijing Kaiyin Technology Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Kaiyin Technology Gastrointestinal Main Business and Markets Served

    • Table Beijing Kaiyin Technology Gastrointestinal Product Portfolio

    • Table CSPC Company Details

    • Table CSPC Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSPC Gastrointestinal Main Business and Markets Served

    • Table CSPC Gastrointestinal Product Portfolio

    • Table Chengdu Tiantaishan Pharmaceutical Company Details

    • Table Chengdu Tiantaishan Pharmaceutical Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chengdu Tiantaishan Pharmaceutical Gastrointestinal Main Business and Markets Served

    • Table Chengdu Tiantaishan Pharmaceutical Gastrointestinal Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Gastrointestinal Main Business and Markets Served

    • Table Abbott Gastrointestinal Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Gastrointestinal Main Business and Markets Served

    • Table Johnson & Johnson Gastrointestinal Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Gastrointestinal Main Business and Markets Served

    • Table GlaxoSmithKline Gastrointestinal Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Gastrointestinal Main Business and Markets Served

    • Table Sanofi Gastrointestinal Product Portfolio

    • Table Solvay Company Details

    • Table Solvay Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Solvay Gastrointestinal Main Business and Markets Served

    • Table Solvay Gastrointestinal Product Portfolio

    • Table Jiangsu Aosaikang Pharmaceutical Company Details

    • Table Jiangsu Aosaikang Pharmaceutical Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Aosaikang Pharmaceutical Gastrointestinal Main Business and Markets Served

    • Table Jiangsu Aosaikang Pharmaceutical Gastrointestinal Product Portfolio

    • Table Shire Pharmaceuticals Company Details

    • Table Shire Pharmaceuticals Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Pharmaceuticals Gastrointestinal Main Business and Markets Served

    • Table Shire Pharmaceuticals Gastrointestinal Product Portfolio

    • Table Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details

    • Table Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Main Business and Markets Served

    • Table Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Product Portfolio

    • Table Roche Company Details

    • Table Roche Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Gastrointestinal Main Business and Markets Served

    • Table Roche Gastrointestinal Product Portfolio

    • Table Eli Lilly Company Details

    • Table Eli Lilly Gastrointestinal Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Gastrointestinal Main Business and Markets Served

    • Table Eli Lilly Gastrointestinal Product Portfolio

    • Figure Global Esophagus Diseases Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stomach Trouble Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colon Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Small Intestinal Diseases Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liver Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pancreatic Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gallbladder Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical And Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Outpatient Surgical Centers And Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic And Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Consumption Forecast by Country (2022-2028)

    • Table North America Gastrointestinal Consumption Forecast by Country (2022-2028)

    • Figure United States Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastrointestinal Consumption Forecast by Country (2022-2028)

    • Figure Germany Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Gastrointestinal Consumption Forecast by Country (2022-2028)

    • Figure China Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Gastrointestinal Consumption Forecast by Country (2022-2028)

    • Figure Brazil Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Gastrointestinal Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Gastrointestinal Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Gastrointestinal Consumption Forecast by Country (2022-2028)

    • Figure Australia Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.